Innovate VATE Healthcare — Remaining performance obligation period
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Innovate in its filing.
Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1.
The official record: Innovate’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Innovate's healthcare — remaining performance obligation period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Innovate's healthcare — remaining performance obligation period?
- Innovate (VATE) reported healthcare — remaining performance obligation period of $0 in Q1 2026.
- What does healthcare — remaining performance obligation period mean?
- This metric represents the estimated time duration over which the company expects to satisfy its remaining performance obligations for the healthcare segment. It provides insight into the long-term visibility of the healthcare revenue pipeline and the average contract duration. Investors use this to gauge the stability and predictability of future healthcare service delivery.